Received: July 2016, Accepted: October 2016 Background: Cadmium (Cd) is an extremely toxic metal and environmental exposure to Cd has been particularly problematic in the world. Oral exposure to Cd may result in adverse effects on a number of tissues, the immune system, and the cardiovascular system. Compounds containing Cd are also carcinogenic. The presence of Cd in drinking water resources in the southeastern region of Rafsanjan plain (Iran) at concentrations greater than acceptable limits may result in various adverse health effects. The aim of this research was to test the chelation potency of deferasirox (DFS or ICL670), a tridentate metal chelator, and deferiprone (L 1 ), a bidentate metal chelator, in the mobilization of Cd in Cd-exposed rats as a biological model. Materials and Methods: Male Wistar rats were exposed to 40 mg/kg body weight of cadmium chloride in drinking water for 6 weeks, followed by treatment with DFS (100 mg/kg body weight, oral, once daily) and L 1 (100 mg/kg body weight, oral, once daily), alone or in combination, for 7 consecutive days. After chelation therapy, the rats were anesthetized by ether vapor and immobilized by cervical dislocation. Then, their heart, liver, kidneys, intestine, and blood were sampled for clinical hematological variables and determination of Cd and Fe concentration by inductively coupled plasma optical emission spectrometry (ICP-OES). The data were subjected to statistical analysis using Student's t-test. All Ρ values of less than 0.05 were considered significant.
Introduction
Cadmium is a toxic metalloid widely present around the world particularly in soil, water, or contaminated food. Cd is primarily used in metal plating and coating operations, including transportation equipment, machinery and baking enamels, photography, and television phosphors. It is also used in nickel-cadmium and solar batteries, and in pigments (1) . Cd is regularly found in ores together with zinc, copper, and lead. Therefore, volcanic activity is one natural reason for a temporary increase in environmental Cd concentrations. Phosphate fertilizers also show a high Cd load. Acute exposure to Cd fumes may cause flulike symptoms including chills, fever, and muscle ache sometimes referred to as "the cadmium blues". Symptoms may resolve after a week if there is no respiratory damage. More severe exposures can cause tracheobronchitis, pneumonitis, and pulmonary edema. Symptoms of inflammation may start hours after the * exposure and include coughs, dryness and irritation of the nose and throat, headache, dizziness, weakness, fever, chills, and chest pain. (13) . Another developed orally active chelating agent is deferiprone (1,2-dimethyl-3-hydroxypyrid-4-one or L 1 ), which is rapidly absorbed in the gastrointestinal tract and normally appears in serum a few minutes after oral administration. The main excretion route is the kidneys. L 1 is a bidentate iron chelator forming a 3:1 complex with Fe and it is likely to act intracellular (14, 15) . The presence of Cd in drinking water resources of Rafsanjan plain at concentrations greater than acceptable limits may result in various adverse health effects. The therapeutic efficacy of DFS and L 1 in reducing Cd concentration in Cd-exposed rats as a biological model was investigated in the present study.
Material and Methods
All the chemicals used in this work were of either analytical grade or of extra pure grade of the highest purity available locally. Cadmium chloride, deferiprone, and other materials were purchased from Merck Chemicals Co. (Germany) and deferasirox was purchased from Novartis Co. (Basel. Switzerland). Male Wistar rats were obtained from the animal house facility of Kerman Neuroscience Research Center (Iran). The animals were kept under a controlled light/dark (12/12 hours) schedule. The rats were divided randomly into control and experimental groups. They were treated in groups and were housed in wellcleaned sterilized cages in an air-conditioned room with the temperature maintained at 22 ± 2 ºC and 50% humidity. The Animal Ethical Committee of Payame Noor University and Kerman Neuroscience Research Center approved the protocols for the experiments. Experimental Groups: In order to evaluate the efficacy of chelators (DFS and L 1 ) in removing Cd in Cd-exposed rats, experiments were performed on Wistar male rats (220 ± 12 g). The animals were classified into 2 groups. The control group (n = 5) was given normal food and distilled water to drink. The concentrations of Cd and Fe in the control group rats were compared with the groups that received Cd and chelators. The toxic groups (n = 25) were given water containing 40 mg/kg body weight Cd 2+ as cadmium chloride for 42
days. In order to compare the Cd and Fe concentrations in tissues, before and after chelation therapy, one group was selected (Vehicle Cd and Vehicle Fe) and sacrificed before chelation therapy. Other Cd-exposed animals were divided into 4 sub-groups of 5 rats each and given the following treatment for 7 consecutive days:  Group control chelator (No treatment)  Group L 1 (100 mg/kg body weight, oral, once daily)  Group DFS (100 mg/kg body weight, oral, once daily)  Group DFS+L 1 (50 and 50 mg/kg body weight, respectively, oral, once daily) All animals of each group were sacrificed under light ether anesthesia, 48 hours after the last dosing. Kidneys, heart, liver, and intestine samples were weighed, dried, and collected for determination of Cd and Fe concentration. The samples were placed in an oven at 60 ºC for 3 days. Then, 1 g of each sample was digested by 1 ml of HNO 3 (10 M). After digestion, the solutions were vaporized with the addition of 0.5 ml of H 2 O 2 (30%) under a hood. Subsequently, the fragments were diluted with distilled water to 10 ml volume. Determination of Cd and Fe in samples was performed using inductively coupled plasma optical emission spectrometry (ICP-OES) (Vista-MPX, Varian Inc., CA, USA). The values are expressed as mean values (at least three separate determinations) ± standard error of the mean (SEM). The data were subjected to statistical analysis using Student's t-test. All Ρ values of less than 0.05 were considered significant. Clinical hematological variables: Blood was collected through cardiac puncture in heparinized tubes and the hemoglobin (Hb) level, platelet (PLT) count, red blood cell (RBC) count, and white blood cell (WBC) count were measured using a hematology analyzer (model K4500, Sysmex Corp., Kobe, Japan).
Results
Oral exposure to Cd may result in adverse effects on a number of tissues, including kidney, liver, bone, testes, the immune system, and the cardiovascular system. In humans, death is usually due to excessive fluid loss as a result of vomiting and diarrhea. Lethal doses in humans have been reported to range from 1,500 to 8,900 mg, corresponding to doses of about 20 to 130 mg/kg in a 70 kg adult (16) . The effects of DFS and L 1 chelators on Cd concentration in various tissues are presented in table 1. Values are presented as mean ± SEM (n = 5); *Significant at Ρ < 0.05 when compared with control
The maximum amount of Cd accumulation was observed in the kidneys and liver, respectively. In order to investigate the spontaneous elimination of Cd from the body by the biological system, the control chelator group was treated without chelation therapy and the removal of Cd by the biological system in this group was not noticeable. After the chelation therapy, the obtained results indicated that Cd concentration had significantly reduced in all tissues. There was a statistical difference between DFS and L 1 in reducing the amount of Cd in various tissues.
As single therapy efficiencies of chelators were compared in this study, it was found that DFS was more effective in decreasing Cd level in all tissues, whereas L 1 was more effective in reducing Cd level in the kidneys. DFS) were observed on WBC, RBC, and Hb and PLT count showed a decrease in the Cd-exposed rats. Cd had no effect on these variables in the present study. This can be attributed to the short duration of Cd exposure. Treatment with DFS and DFS + L 1 provided significant recovery in terms of PLT counts.
Conclusion
Chelation therapy is one of the most effective ways to remove toxic metals from the biological system. The comparison of the results indicates that the combined therapy (DFS + L 1 ) enhanced the removal of Cd from rat organs considerably. Each of the chelators (DFS and L 1 ) has a different target tissue. Therefore, their combination can effectively help the removal Cd from various tissues. This study might be effective for preliminary testing of the efficacy of chelating agents in the removal of Cd. Therefore, after essential preclinical experiments, the same study can be suggested for human administration.
